powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1316320179
Daniel Castro
M.D.
Hematology-Oncology
Orange City,
FL
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
Healthparse Signals
Monitor this provider for changes — dated NPI change events
FACILITY AFFILIATIONS
Hospital & Facility Affiliations (2)
CCN 100045
Hospital
CCN 100072
Hospital
PRESCRIBING · PART D · 2024
Total Rx claims
1,106
Beneficiaries
—
Total drug cost
$3.8M
Distinct drugs
40
Brand share
55.2%
Top prescribed drugs
Apixaban
114 claims
Letrozole
76 claims
Anastrozole
71 claims
Rivaroxaban
70 claims
Palonosetron Hcl
49 claims
QUALITY · MIPS · 2024
Final MIPS score
100.0
Quality
91.5
Cost
0.0
Improvement activities
40.0
Promoting interop.
0.0
Payment adjustment
1.05%
Group
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
2,466
Unique beneficiaries
—
Total services
20,823
Distinct HCPCS
43
Medicare payment
$241K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 737 Hematology-Oncology providers in FL — above median (cohort median 1,932).
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
Total received
$419
Payment records
19
By payment type
Food and Beverage
$419
Top paying entities
Food and Beverage
$419
